中国药业2017，Vol.26Issue(23)：40-41,2.DOI:10.3969/j.issn.1006-4931.2017.23.013
瑞舒伐他汀联合曲美他嗪对冠状动脉粥样硬化性心脏病患者心功能的影响
Effect of Rosuvastatin Combined with Trimetazidine on Cardiac Function in Patients with Coronary Heart Disease
安波尔 1刘文娜 1张亚芳1
作者信息
- 1. 首都医科大学宣武医院,北京 100053
- 折叠
摘要
Abstract
Objective To investigate the clinical effect of rosuvastatin combined with trimetazidine for treating coronary heart disease and its effect on cardiac function. Methods Totally 110 patients with coronary heart disease admitted to our hospital from December 2013 to February 2017 were selected and divided into the two groups. The control group was treated with rosuvastatin, on this basis, the observation group was treated with trimetazidine. Results After treatment, the cardiac function indexes of the two groups were significantly improved, and the observation group was significantly better than the control group ( P< 0. 05 ) . The levels of TC and LDL-C in the observation group were significantly lower than those before treatment, and the observation group was significantly better than the control group ( P< 0. 05 ) . The incidence rate of readmission caused by myocardial infarction and angina pectoris was in the observation group 9. 09%, which was significantly lower than 23. 64% in the control group ( P< 0. 05 ) . Conclusion Rosuvastatin combined with trimetazidine can improve cardiac function in patients with coronary heart disease, the curative effect is remarkable, it is worthy of clinical promotion.关键词
冠状动脉粥样硬化性心脏病/瑞舒伐他汀/曲美他嗪/心功能Key words
coronary heart disease/rosuvastatin/trimetazidine/cardiac function分类
医药卫生引用本文复制引用
安波尔,刘文娜,张亚芳..瑞舒伐他汀联合曲美他嗪对冠状动脉粥样硬化性心脏病患者心功能的影响[J].中国药业,2017,26(23):40-41,2.
